{"id":"amoxicillin-omeprazole","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Diarrhea"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-10","effect":"Abdominal pain"},{"rate":"5-10","effect":"Headache"},{"rate":"1-3","effect":"Rash (amoxicillin-related)"},{"rate":"1-2","effect":"Allergic reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amoxicillin is a beta-lactam antibiotic that binds to penicillin-binding proteins and inhibits bacterial cell wall cross-linking, leading to cell lysis. Omeprazole is a proton pump inhibitor that suppresses gastric acid secretion, reducing acid-related damage and potentially enhancing amoxicillin bioavailability in the upper GI tract. This combination is typically used to eradicate Helicobacter pylori infection while minimizing gastric ulceration.","oneSentence":"Amoxicillin kills bacteria by inhibiting cell wall synthesis, while omeprazole reduces gastric acid to protect the stomach lining and improve antibiotic delivery.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:01:32.440Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Helicobacter pylori eradication as part of triple or quadruple therapy"},{"name":"Peptic ulcer disease associated with H. pylori infection"}]},"trialDetails":[{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT06510010","phase":"PHASE2","title":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-12-31","conditions":"Chemotherapy Effect","enrollment":198},{"nctId":"NCT05647278","phase":"PHASE4","title":"Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)","status":"COMPLETED","sponsor":"Zhang Xiaofeng,MD","startDate":"2023-11-01","conditions":"Helicobacter Pylori Infection","enrollment":370},{"nctId":"NCT07294846","phase":"PHASE1","title":"Drug Interaction Study on Linaprazan Glurate Capsules","status":"COMPLETED","sponsor":"Jiangsu Sinorda Biomedicine Co., Ltd","startDate":"2025-09-08","conditions":"Healthy Volunteers, Patients","enrollment":56},{"nctId":"NCT07312721","phase":"PHASE4","title":"Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis","status":"COMPLETED","sponsor":"Azfar Farogh","startDate":"2024-01-05","conditions":"Helicobacter Pylori Infection, Chronic Gastritis, Peptic Ulcer Disease","enrollment":752},{"nctId":"NCT07275827","phase":"PHASE3","title":"Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":88},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT07260006","phase":"NA","title":"Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease","status":"RECRUITING","sponsor":"Can Tho University of Medicine and Pharmacy","startDate":"2024-10-01","conditions":"Helicobacter Pylori Infection, Peptic Ulcer","enrollment":80},{"nctId":"NCT06514274","phase":"PHASE4","title":"Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-09-20","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":558},{"nctId":"NCT06523764","phase":"PHASE4","title":"Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-11-11","conditions":"Helicobacter Pylori Infection Chronic Gastrit","enrollment":208},{"nctId":"NCT06168084","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Yongquan Shi","startDate":"2023-06-06","conditions":"Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer","enrollment":688},{"nctId":"NCT05742568","phase":"PHASE4","title":"Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2022-12-01","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":124},{"nctId":"NCT07040839","phase":"PHASE4","title":"Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-07","conditions":"H Pylori","enrollment":128},{"nctId":"NCT07021729","phase":"PHASE4","title":"Comparison of Two Treatment Regimens of Helicobacter Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-12","conditions":"Helicobacter Pylori Infection","enrollment":156},{"nctId":"NCT06959368","phase":"PHASE4","title":"Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication","status":"RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2025-03-25","conditions":"Helicobacter Pylori Infection","enrollment":484},{"nctId":"NCT06973889","phase":"PHASE2","title":"Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients","status":"COMPLETED","sponsor":"Mashhad University of Medical Sciences","startDate":"2023-12-04","conditions":"HELICOBACTER PYLORI INFECTIONS, Gastrointestinal Disease","enrollment":60},{"nctId":"NCT03365609","phase":"NA","title":"A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children","status":"RECRUITING","sponsor":"Ying HUANG","startDate":"2017-09-20","conditions":"Helicobacter Infections","enrollment":1440},{"nctId":"NCT06851468","phase":"NA","title":"Keverprazan Combined with Amoxicillin for the Treatment of Helicobacter Pylori","status":"NOT_YET_RECRUITING","sponsor":"Key Laboratory for Gastrointestinal Diseases of Gansu Province","startDate":"2025-03-15","conditions":"Helicobacter Pylori","enrollment":264},{"nctId":"NCT06811207","phase":"PHASE3","title":"Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":300},{"nctId":"NCT06823791","phase":"PHASE1, PHASE2","title":"Furazolidone Quadruple Regimen Eradicate H. Pylori Infection","status":"COMPLETED","sponsor":"Liaocheng People's Hospital","startDate":"2022-08-01","conditions":"Helicobacter Pylori Infection, Eradication","enrollment":493},{"nctId":"NCT06603688","phase":"PHASE4","title":"Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.","status":"UNKNOWN","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2023-11-20","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":548},{"nctId":"NCT06162949","phase":"PHASE3","title":"Vonoprazan for Helicobacter Pylori Eradication in Adolescents","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-01-01","conditions":"Treatment Effectiveness","enrollment":242},{"nctId":"NCT06546111","phase":"PHASE1, PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Sadat City University","startDate":"2024-10-01","conditions":"Helicobacter Pylori Infection","enrollment":46},{"nctId":"NCT06502288","phase":"NA","title":"Evaluation of Antibiotic Administration Following Tooth Extraction","status":"NOT_YET_RECRUITING","sponsor":"Chittagong Medical College","startDate":"2025-01-01","conditions":"Tooth Extraction","enrollment":152},{"nctId":"NCT06250634","phase":"NA","title":"Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-02-10","conditions":"Helicobacter Pylori Infection","enrollment":806},{"nctId":"NCT05664685","phase":"PHASE4","title":"Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-10-17","conditions":"Helicobacter Pylori Infection","enrollment":127},{"nctId":"NCT05431075","phase":"PHASE4","title":"Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses","status":"COMPLETED","sponsor":"Shandong University","startDate":"2022-07-01","conditions":"Helicobacter Pylori Infection","enrollment":406},{"nctId":"NCT06318104","phase":"PHASE4","title":"Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole","status":"NOT_YET_RECRUITING","sponsor":"Hospital General de México Dr. Eduardo Liceaga","startDate":"2024-04-19","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT06315478","phase":"PHASE4","title":"Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians","status":"COMPLETED","sponsor":"Helwan University","startDate":"2021-02-01","conditions":"H.Pylori Infection","enrollment":60},{"nctId":"NCT06216639","phase":"","title":"Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection","status":"UNKNOWN","sponsor":"National Institute of Public Health, Slovenia","startDate":"2024-02-01","conditions":"Helicobacter Pylori Infection","enrollment":2000},{"nctId":"NCT05577468","phase":"PHASE3","title":"Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.","startDate":"2022-10-30","conditions":"Helicobacter Pylori Infection","enrollment":561},{"nctId":"NCT02407119","phase":"PHASE3","title":"Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2003-06","conditions":"Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection","enrollment":470},{"nctId":"NCT03779087","phase":"NA","title":"Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection","status":"COMPLETED","sponsor":"Ping-I (William) Hsu, M.D.","startDate":"2018-07-11","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT06101420","phase":"PHASE3","title":"Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Helicobacter Pylori Eradication","enrollment":232},{"nctId":"NCT01133951","phase":"NA","title":"Helicobacter Pylori Eradication to Prevent Gastric Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jie-Jun Wang","startDate":"2010-06","conditions":"Helicobacter Infections, Stomach Neoplasms","enrollment":3000},{"nctId":"NCT06065267","phase":"PHASE4","title":"Levofloxacin Concomitant Versus Levofloxacin Sequential","status":"NOT_YET_RECRUITING","sponsor":"Damascus Hospital","startDate":"2024-01-02","conditions":"Helicobacter Pylori Infection","enrollment":150},{"nctId":"NCT04198363","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Takeda","startDate":"2020-04-30","conditions":"Helicobacter Pylori","enrollment":510},{"nctId":"NCT04753437","phase":"PHASE1","title":"A Study of Vonoprazan in Adults With Helicobacter Pylori","status":"COMPLETED","sponsor":"Takeda","startDate":"2021-04-06","conditions":"Helicobacter Pylori","enrollment":44},{"nctId":"NCT05870683","phase":"NA","title":"Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）","status":"UNKNOWN","sponsor":"Yanqing Li","startDate":"2023-05-24","conditions":"Helicobacter Pylori Infection","enrollment":368},{"nctId":"NCT05863858","phase":"PHASE3","title":"Eradication of H. Pylori Infection With Moxifloxacin","status":"COMPLETED","sponsor":"Iyad Naeem Muhammad, PhD","startDate":"2020-06-01","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to","enrollment":162},{"nctId":"NCT05861687","phase":"PHASE2, PHASE3","title":"Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children","status":"COMPLETED","sponsor":"Finni Kollins","startDate":"2021-08-01","conditions":"Helicobacter Pylori Infection","enrollment":51},{"nctId":"NCT05850117","phase":"NA","title":"Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","startDate":"2020-02-10","conditions":"Helicobacter Pylori Eradication","enrollment":240},{"nctId":"NCT02373280","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":600},{"nctId":"NCT05802888","phase":"PHASE4","title":"Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2023-03-12","conditions":"Helicobacter Pylori Infection","enrollment":260},{"nctId":"NCT05173493","phase":"","title":"The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure","status":"COMPLETED","sponsor":"Shandong University","startDate":"2021-12-30","conditions":"Helicobacter Pylori Infection","enrollment":670},{"nctId":"NCT05726734","phase":"PHASE4","title":"Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2023-02-06","conditions":"Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT05438550","phase":"PHASE4","title":"14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2023-02-14","conditions":"Helicobacter Pylori Infection","enrollment":258},{"nctId":"NCT05342532","phase":"PHASE4","title":"High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-06-12","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT04660123","phase":"PHASE4","title":"A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":959},{"nctId":"NCT04678492","phase":"PHASE4","title":"Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":658},{"nctId":"NCT05432115","phase":"PHASE4","title":"Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2022-06-25","conditions":"Helicobacter Pylori Infection","enrollment":407},{"nctId":"NCT05590286","phase":"PHASE4","title":"A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"First People's Hospital of Hangzhou","startDate":"2022-06-01","conditions":"Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor","enrollment":100},{"nctId":"NCT05620589","phase":"","title":"The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2022-11-11","conditions":"Helicobacter Pylori Infection","enrollment":626},{"nctId":"NCT04879992","phase":"NA","title":"Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2021-05-07","conditions":"Helicobacter Pylori Infection","enrollment":413},{"nctId":"NCT04810793","phase":"","title":"The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure","status":"COMPLETED","sponsor":"Shandong University","startDate":"2020-07-01","conditions":"Helicobacter Pylori","enrollment":820},{"nctId":"NCT05586464","phase":"PHASE1","title":"Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine","status":"UNKNOWN","sponsor":"Liaocheng People's Hospital","startDate":"2022-11-01","conditions":"Helicobacter Pylori Infection, Traditional Chinese Medicine, Eradication","enrollment":600},{"nctId":"NCT02552641","phase":"PHASE4","title":"Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole","status":"WITHDRAWN","sponsor":"EMS","startDate":"2015-09","conditions":"Helicobacter Pylori Infection","enrollment":""},{"nctId":"NCT05176821","phase":"NA","title":"Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-01-01","conditions":"H. Pylori Infection","enrollment":186},{"nctId":"NCT04178187","phase":"NA","title":"The Role of Probiotics in the Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Evangelismos Hospital","startDate":"2019-10-02","conditions":"Helicobacter Pylori Infection","enrollment":660},{"nctId":"NCT05189444","phase":"NA","title":"The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Huazhong University of Science and Technology","startDate":"2022-03-25","conditions":"Helicobacter Pylori Infection","enrollment":672},{"nctId":"NCT05250050","phase":"PHASE4","title":"Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-03-25","conditions":"Helicobacter Pylori Infection","enrollment":388},{"nctId":"NCT05237115","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-05-05","conditions":"Gastritis, Peptic Ulcer, Dyspepsia","enrollment":600},{"nctId":"NCT04558502","phase":"PHASE4","title":"Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-01-05","conditions":"Helicobacter Pylori Eradication","enrollment":339},{"nctId":"NCT05100446","phase":"EARLY_PHASE1","title":"Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Unidade Local de Saúde do Alto Ave, EPE","startDate":"2021-05-01","conditions":"Helicobacter Pylori Infection, Gastritis, Gastric Cancer","enrollment":100},{"nctId":"NCT03688828","phase":"NA","title":"Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2018-11-11","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT04786938","phase":"PHASE4","title":"Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy","status":"COMPLETED","sponsor":"Universidad San Francisco de Quito","startDate":"2016-04-07","conditions":"Gut Resistome","enrollment":72},{"nctId":"NCT04024527","phase":"PHASE4","title":"High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2019-07-25","conditions":"Helicobacter Pylori Infection","enrollment":306},{"nctId":"NCT03592069","phase":"PHASE4","title":"Concomitant Versus Hybrid Regimen for H. Pylori Eradication","status":"COMPLETED","sponsor":"Alexandra Hospital, Athens, Greece","startDate":"2018-02-21","conditions":"H.Pylori Infection, H.Pylori Gastrointestinal Disease, H. Pylori Associated Phlegmonous Gastritis","enrollment":345},{"nctId":"NCT04901663","phase":"PHASE4","title":"Vonoprazan in Helicobacter Pylori Treatment an RCT","status":"COMPLETED","sponsor":"Dow University of Health Sciences","startDate":"2021-06-21","conditions":"Helicobacter Pylori Infection","enrollment":179},{"nctId":"NCT04991584","phase":"NA","title":"Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2021-08-04","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT04907747","phase":"PHASE4","title":"Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2021-05-18","conditions":"Helicobacter Pylori Infection","enrollment":234},{"nctId":"NCT03757650","phase":"PHASE4","title":"THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY","status":"COMPLETED","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2018-10-01","conditions":"Helicobacter Pylori Infection, Obesity, Morbid","enrollment":3},{"nctId":"NCT04652284","phase":"PHASE3","title":"Effectiveness of Rifabutin for Treatment of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2021-05-01","conditions":"Helicobacter Infections, Resistance Bacterial, Gastritis H Pylori","enrollment":300},{"nctId":"NCT04721704","phase":"NA","title":"Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children","status":"UNKNOWN","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2020-09-14","conditions":"H Pylori Gastritis","enrollment":36},{"nctId":"NCT04626193","phase":"PHASE4","title":"LOAD VS Levofloxacine Concomitant","status":"UNKNOWN","sponsor":"Damascus Hospital","startDate":"2020-10-31","conditions":"Helicobacter Pylori Infection","enrollment":80},{"nctId":"NCT04617613","phase":"PHASE4","title":"Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2016-09","conditions":"Helicobacter Pylori Infection","enrollment":603},{"nctId":"NCT03908619","phase":"PHASE4","title":"A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis","status":"UNKNOWN","sponsor":"Changi General Hospital","startDate":"2019-04-16","conditions":"Helicobacter Pylori Infection","enrollment":252},{"nctId":"NCT04348786","phase":"PHASE4","title":"Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori","status":"COMPLETED","sponsor":"Damascus Hospital","startDate":"2019-02-01","conditions":"Helicobacter Pylori Infection","enrollment":78},{"nctId":"NCT04525664","phase":"EARLY_PHASE1","title":"Assessment and Management of Chronic Dyspepsia in Eastern Uganda","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2018-10-01","conditions":"Helicobacter Pylori Infection, Dyspepsia","enrollment":376},{"nctId":"NCT04445948","phase":"PHASE4","title":"Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2019-11-30","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT04359966","phase":"NA","title":"Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia","status":"UNKNOWN","sponsor":"Slovenian Society for Gastroenterology and Hepatology","startDate":"2020-05-10","conditions":"Helicobacter Pylori Infection, Eradication Treatments","enrollment":560},{"nctId":"NCT03198507","phase":"PHASE3","title":"ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2017-06-18","conditions":"Helicobacter Pylori Infection, Dyspepsia","enrollment":455},{"nctId":"NCT03726099","phase":"PHASE4","title":"Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2019-03-15","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT00339768","phase":"PHASE3","title":"A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1995-07-01","conditions":"Precancerous Gastric Lesions","enrollment":3411},{"nctId":"NCT04034641","phase":"PHASE4","title":"Effect of Probiotics on Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Hangzhou Grand Biologic Pharmaceutical, Inc.","startDate":"2019-06-17","conditions":"Helicobacter Pylori Eradication","enrollment":238},{"nctId":"NCT04039412","phase":"PHASE4","title":"Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt","status":"COMPLETED","sponsor":"Ayman Magd Eldin Mohammad Sadek","startDate":"2018-06-01","conditions":"Helicobacter Pylori Infection","enrollment":330},{"nctId":"NCT02108704","phase":"NA","title":"Helicobacter Pylori Eradication Study in Parkinson's Disease","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2013-12","conditions":"Parkinson's Disease, Helicobacter Pylori Infection","enrollment":75},{"nctId":"NCT01980095","phase":"PHASE3","title":"ERADICATE Hp - Treating Helicobacter Pylori With RHB-105","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2013-11","conditions":"Dyspepsia, Helicobacter Pylori Infection","enrollment":119},{"nctId":"NCT04090021","phase":"PHASE4","title":"Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.","status":"UNKNOWN","sponsor":"Konstantopoulio-Patission General Hospital of Nea Ionia","startDate":"2019-09-01","conditions":"Helicobacter Pylori Infection","enrollment":304},{"nctId":"NCT03609892","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2018-08-01","conditions":"Gastric Ulcer, Chronic Gastritis, Gastric Cancer","enrollment":658},{"nctId":"NCT03557437","phase":"PHASE4","title":"High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-05-25","conditions":"Helicobacter Pylori Infection","enrollment":216},{"nctId":"NCT03220542","phase":"PHASE4","title":"The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2016-01","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT03968302","phase":"PHASE2","title":"ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION","status":"COMPLETED","sponsor":"Ziauddin University","startDate":"2018-06-01","conditions":"Helicobacter Pylori Infection","enrollment":196},{"nctId":"NCT02978157","phase":"NA","title":"Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2015-02","conditions":"Helicobacter Pylori Infection","enrollment":102},{"nctId":"NCT02547012","phase":"NA","title":"Comparison of Two Rescue Therapies for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2013-11","conditions":"Helicobacter Pylori Infection","enrollment":51},{"nctId":"NCT03383003","phase":"NA","title":"Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-03-01","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT03021590","phase":"PHASE4","title":"Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori","status":"WITHDRAWN","sponsor":"Damascus Hospital","startDate":"2017-06-01","conditions":"Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":""},{"nctId":"NCT03658733","phase":"PHASE4","title":"A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2018-12-15","conditions":"Helicobacter Pylori Infection","enrollment":120},{"nctId":"NCT03730766","phase":"PHASE4","title":"Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-08-01","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT03405584","phase":"PHASE4","title":"High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-01-03","conditions":"Helicobacter Pylori Infection","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Amoxicillin/omeprazole","genericName":"Amoxicillin/omeprazole","companyName":"National Cancer Institute (NCI)","companyId":"national-cancer-institute-nci","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amoxicillin kills bacteria by inhibiting cell wall synthesis, while omeprazole reduces gastric acid to protect the stomach lining and improve antibiotic delivery. Used for Helicobacter pylori eradication as part of triple or quadruple therapy, Peptic ulcer disease associated with H. pylori infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}